April 29, 2026 GenRPT Finance
Genomics, cell therapy, and platform technologies are pushing the limits...
Valuing early-stage biotech companies with no revenue is one of...
Biotech and life sciences beyond pharma are expanding the scope...
AI demand is reshaping semiconductor equity research by disrupting one...
Geopolitical risk is now embedded in almost every semiconductor equity...
The distinction between fabless companies and integrated device manufacturers is...
